These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 23440809
21. Creatine and creatine analogues in hypertension and cardiovascular disease. Horjus DL, Oudman I, van Montfrans GA, Brewster LM. Cochrane Database Syst Rev; 2011 Nov 09; 2011(11):CD005184. PubMed ID: 22071819 [Abstract] [Full Text] [Related]
24. Legacy Effect of Intensive Blood Glucose Control on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Very High Risk or Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials. Zhang X, Liu Y, Zhang F, Li J, Tong N. Clin Ther; 2018 May 09; 40(5):776-788.e3. PubMed ID: 29656857 [Abstract] [Full Text] [Related]
25. Effect of Vitamin B6, B9, and B12 Supplementation on Homocysteine Level and Cardiovascular Outcomes in Stroke Patients: A Meta-Analysis of Randomized Controlled Trials. Kataria N, Yadav P, Kumar R, Kumar N, Singh M, Kant R, Kalyani V. Cureus; 2021 May 11; 13(5):e14958. PubMed ID: 34123655 [Abstract] [Full Text] [Related]
26. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bønaa KH, Spence JD, Nygård O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R, B-Vitamin Treatment Trialists' Collaboration. Arch Intern Med; 2010 Oct 11; 170(18):1622-31. PubMed ID: 20937919 [Abstract] [Full Text] [Related]
27. Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map. Zhu J, Yu X, Zheng Y, Li J, Wang Y, Lin Y, He Z, Zhao W, Chen C, Qiu K, Wu J. Lancet Diabetes Endocrinol; 2020 Mar 11; 8(3):192-205. PubMed ID: 32006518 [Abstract] [Full Text] [Related]
29. The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial. Gommans J, Yi Q, Eikelboom JW, Hankey GJ, Chen C, Rodgers H, VITATOPS trial study group. BMC Geriatr; 2013 Sep 03; 13():88. PubMed ID: 24004645 [Abstract] [Full Text] [Related]
30. Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about? Faeh D, Chiolero A, Paccaud F. Swiss Med Wkly; 2006 Dec 02; 136(47-48):745-56. PubMed ID: 17225194 [Abstract] [Full Text] [Related]
34. [Hyperhomocysteinemia in patients with cardiovascular disease]. Baszczuk A, Kopczyński Z. Postepy Hig Med Dosw (Online); 2014 Jan 02; 68():579-89. PubMed ID: 24864108 [Abstract] [Full Text] [Related]
35. Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients. Bavishi C, Bangalore S, Messerli FH. J Am Coll Cardiol; 2017 Feb 07; 69(5):486-493. PubMed ID: 28153104 [Abstract] [Full Text] [Related]
37. Homocysteine and risk of cardiovascular disease among postmenopausal women. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. JAMA; 1999 May 19; 281(19):1817-21. PubMed ID: 10340369 [Abstract] [Full Text] [Related]
39. Vitamins for the management of cardiovascular disease: a simple solution to a complex problem? Lenhart SE, Nappi JM. Pharmacotherapy; 1999 Dec 19; 19(12):1400-14. PubMed ID: 10600089 [Abstract] [Full Text] [Related]
40. Association between B vitamins supplementation and risk of cardiovascular outcomes: a cumulative meta-analysis of randomized controlled trials. Zhang C, Wang ZY, Qin YY, Yu FF, Zhou YH. PLoS One; 2014 Dec 19; 9(9):e107060. PubMed ID: 25238614 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]